Menu

Biotechnology & Life Sciences

Lathrop Gage provides extensive expertise and a proven track record for clients in the Biotechnology & Life Sciences industries for all areas of intellectual property representation, including IP portfolio building, prosecution, due diligence, transactions and litigation.

Lathrop Gage represents clients in the biotechnology and life sciences sector ranging from large pharmaceutical companies to small start-ups and venture capital groups. We have nearly 70 attorneys, patent agents and technical specialists who have focused expertise in biotechnology, chemistry, high technology, patent litigation and licensing. 

Lathrop Gage has a nationwide presence, with offices from Boston to Los Angeles. In keeping with the firm’s focus on the intellectual property arena, nearly all of those offices, including Boston, Boulder, Kansas City, and Los Angeles have significant IP practices. Our attorneys are supported by a team of dedicated paralegals that manages and administers the myriad deadlines and technical requirements of patent and trademark offices in the United States and abroad.

Industry Experience:

  • Novel chemical entities
  • Small molecule pharmaceuticals
  • Prodrugs
  • Implantable and external medical devices
  • Biologics
  • Gene therapy
  • Peptide therapeutics/chemistry
  • Biomarkers and diagnostics
  • Antibodies, CAR-T and immunotherapies
  • Oligonucleotide therapeutics including RNAi/siRNA/miRNA and anti-sense
  • FDA label developments

Additional Highlights:

  • Assist 3 of the top 10 global pharmaceutical companies with building out comprehensive and global patent estates in connection with multiple biologics and small molecule products in several therapeutic disease areas, including oncology, immunology, neurology and cardiology.
  • Conduct freedom-to-operate (FTO) analyses, IP landscape reviews, and clearance work in connection with both early- and late-stage pharmaceutical products.
  • Provide ongoing client counseling and portfolio management in connection with several marketed antibody biologics and small molecules.
  • Serve as patent counsel for startup, emerging and mature biotechnology companies across the U.S. and Europe in connection with a variety of platform technologies and product pipelines in areas as diverse as antibody engineering, genome engineering, nucleic acid therapeutics, gene therapy (AAV, Adenovirus), and small molecule advancements.

News

Publications

Press Releases

Legal Alerts